Endoclear

San Ramon, United States Founded: 2009 • Age: 17 yrs Acquired By Avanos
Devices to clear away film and blockages in breathing tubes
Request Access

About Endoclear

Endoclear is a company based in San Ramon (United States) founded in 2009 by Brad Vazales was acquired by Avanos in November 2019.. Endoclear has raised $8.37 million across 7 funding rounds from investors including Avanos. Endoclear operates in a competitive market with competitors including Belluscura, Lungpacer, hemovent, ALung and OneBreath, among others.

  • Headquarter San Ramon, United States
  • Founders Brad Vazales
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Endoclear Llc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $8.37 M (USD)

    in 7 rounds

  • Latest Funding Round
    $782.79 K (USD), Series A

    May 23, 2014

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Avanos

    (Nov 05, 2019)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Endoclear

Endoclear has successfully raised a total of $8.37M across 7 strategic funding rounds. The most recent funding activity was a Series A round of $782.79 thousand completed in May 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series A — $782,790
  • First Round

    (15 Feb 2010)

  • Investors Count
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2014 Amount Series A - Endoclear Valuation

investors

May, 2014 Amount Seed - Endoclear Valuation

investors

Oct, 2011 Amount Seed - Endoclear Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Endoclear

Endoclear has secured backing from 1 investor. Prominent investors backing the company include Avanos. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Medical devices for pain management and enteral feeding are manufactured.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Endoclear

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Endoclear

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Endoclear Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Endoclear

Endoclear operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Belluscura, Lungpacer, hemovent, ALung and OneBreath, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Provider of medical devices for laparoscopic procedures
domain founded_year HQ Location
Neurostimulation-based pacer for diaphragm strength is developed.
domain founded_year HQ Location
Equipment for extracorporeal life support and CO2 removal is developed.
domain founded_year HQ Location
Extracorporeal CO2 removal systems are developed to supplement mechanical ventilation.
domain founded_year HQ Location
Portable mechanical ventilators for intensive care patients are developed.
domain founded_year HQ Location
Medical devices for emergency airway management are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Endoclear

Frequently Asked Questions about Endoclear

When was Endoclear founded?

Endoclear was founded in 2009 and raised its 1st funding round 1 year after it was founded.

Where is Endoclear located?

Endoclear is headquartered in San Ramon, United States. It is registered at San Ramon, California, United States.

Who is the current CEO of Endoclear?

Brad Vazales is the current CEO of Endoclear. They have also founded this company.

Is Endoclear a funded company?

Endoclear is a funded company, having raised a total of $8.37M across 7 funding rounds to date. The company's 1st funding round was a Seed of $2.4M, raised on Feb 15, 2010.

What does Endoclear do?

Endoclear develops devices to clear away film and blockages in breathing tubes. The company has developed endOclear, a device that removes mucus and secretions, biofilm, and bacteria from ventilated patients endotracheal tubes and is meant for patients who need a ventilator for more than 48 hours. It combines a clearing technology that physically removes mucus, secretions, and biofilm from the walls of endotracheal tubes in a closed system with suction.

Who are the top competitors of Endoclear?

Endoclear's top competitors include Belluscura, Lungpacer and hemovent.

Who are Endoclear's investors?

Endoclear has 1 investor. Key investors include Avanos.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available